Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension
Year: 2012
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: European Respiratory Journal
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2102522559
